Archive: 2026/01 - Page 3

Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Launch

Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Launch

Paragraph IV certifications let generic drug makers challenge brand patents before launch, speeding up affordable medicine. Learn how the Hatch-Waxman Act enables this legal battle - and why it saves patients billions.

Read More
Latex Allergy: Cross-Reactivity and Workplace Management

Latex Allergy: Cross-Reactivity and Workplace Management

Latex allergy affects 1-2% of the general population and up to 67% of people with spina bifida. Learn how cross-reactivity with foods like bananas and avocados increases risk, and how workplaces can prevent reactions through non-latex alternatives and safety policies.

Read More
Skin Rashes and Medication-Induced Dermatitis: What Patients Should Know

Skin Rashes and Medication-Induced Dermatitis: What Patients Should Know

Learn how to recognize dangerous skin rashes caused by medications, which drugs are most likely to trigger them, and what to do if you develop one. Know the signs of life-threatening reactions and how to prevent future problems.

Read More
How to Prevent Compounding Errors for Customized Medications

How to Prevent Compounding Errors for Customized Medications

Preventing errors in customized medications requires strict adherence to USP standards, dual verification, proper labeling, and staff training. Learn how accredited compounding pharmacies reduce risks and keep patients safe.

Read More